Abstract
Genetic and epigenetic studies of gene variants reveal a potential genomic target for treating hemoglobin disorders.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 206-207 |
| Number of pages | 2 |
| Journal | Science |
| Volume | 342 |
| Issue number | 6155 |
| DOIs | |
| State | Published - 2013 |
All Science Journal Classification (ASJC) codes
- General